Cargando…
PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
Autores principales: | Marques, R, Ramos, F, Perpétuo, I, Fernandes, S, Furtado, C, Mourão, AF, Martins, F, Canhão, H, Fonseca, JE, Pereira da Silva, JA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043502/ http://dx.doi.org/10.1186/1546-0096-11-S2-P107 |
Ejemplares similares
-
PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up
por: Marques, R, et al.
Publicado: (2013) -
PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013) -
PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013) -
PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
por: Zajc Avramovič, M, et al.
Publicado: (2013) -
PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis
por: Vastert, S, et al.
Publicado: (2013)